Helios Neopharma
Helios Neopharma is a technology platform that provides AI-driven analysis and treatments for central nervous system disorders.
Helios Neopharma is active in the artificial intelligence (ai), biotechnology, pharmaceutical space based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Helios Neopharma is positioned in artificial intelligence (ai), biotechnology, pharmaceutical, a segment that rewards a clear, focused offering.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Private company.
Recorded headcount: c_00001_00010 employees.
| Sector | Artificial Intelligence (AI), Biotechnology, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: www.heliosneopharma.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account